Urological cancer, Malmö
1 – 10 of 563
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Peritoneal recurrence following nephrectomy for localized renal cancer : A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study–UroCCR 124)
- Contribution to journal › Article
-
Mark
Improved sex-specific cardiovascular risk prediction with multi-omics data in people with type 2 diabetes
- Contribution to journal › Article
- 2025
-
Mark
Adverse events during radical prostatectomy and their association with recurrence and death
- Contribution to journal › Article
-
Mark
Dietary Patterns in Prostate Cancer Prevention and Management : A Systematic Review of Prospective Cohort Studies and Randomized Clinical Trials
- Contribution to journal › Scientific review
-
Mark
Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
- Contribution to journal › Article
-
Mark
SPARC : The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
(2025) In European Urology
- Contribution to journal › Article
-
Mark
Statistics in clinical urology research : fundamental concepts in comparative research
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re : Andreas Josefsson, Marianne Månsson, Kimia Kohestani, et al. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial. Eur Urol 2024;86:223-9
- Contribution to journal › Article
-
Mark
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer
- Contribution to journal › Article
-
Mark
An optimised Bcl-3 inhibitor for melanoma treatment
- Contribution to journal › Article
